or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    STTK B Shattuck Labs, Inc. -2.88
    XOMA C XOMA Corporation -2.59
    CLDI F Calidi Biotherapeutics, Inc. -1.99
    INAB F IN8bio, Inc. -1.96
    BPTH F Bio-Path Holdings Inc -1.88
    LYEL C Lyell Immunopharma, Inc. -1.67
    ALRN D Aileron Therapeutics, Inc. -1.57
    SLS B SELLAS Life Sciences Group, Inc. -1.48
    ARGX D argenx SE -1.33
    ACLX D Arcellx, Inc. -1.13
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Cell Biology Lymphoma Acute Myeloid Leukemia Biopharmaceutical Clinical Medicine Medicine Stem Cell Autoimmune Disease Biology Breast Cancer Cancer Immunotherapy Immunotherapies Inflammation Life Sciences Multiple Myeloma Myelodysplastic Syndrome Non Small Cell Lung Cancer Oncogenes

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    EWK A iShares MSCI Belgium Capped Investable Market Index Fund 6.71
    IBRN D iShares Neuroscience and Healthcare ETF 4.58
    BBH B Market Vectors Biotech ETF 4.45
    MNTL F Tema Neuroscience and Mental Health ETF 3.57
    FBT D First Trust Amex Biotech Index Fund 3.39
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare EWK to BBH Compare EWK to FBT Compare IBRN to BBH

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 3 ALRN Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
        May 2 STTK Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
        May 2 STTK Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M
        May 2 STTK Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
        May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
        May 2 ARGX argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
        May 1 BPTH Looking Into Bio-Path Hldgs's Recent Short Interest
        May 1 SLS Sellas reports positive Phase 2 data from AML study, files for patent
        May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
        May 1 ALRN Aileron Therapeutics announces positive data from its early stage pulmonary fibrosis treatment trial
        May 1 ALRN Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
        May 1 SLS SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
        May 1 ALRN Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
        May 1 CLDI Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
        Apr 30 XOMA XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
        Apr 30 INAB IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
        Apr 29 SLS SELLAS Life Sciences announces IDMC's recommendation of continuing REGAL phase 3 study without modifications
        Apr 29 SLS SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Biopharmaceutical Cancer Medicine Biotechnology Cancer Immunotherapy Immune System Lymphoma Tumor Apoptosis Autoimmune Disease Cancer Treatment Cell Therapy Immunotherapy Life Sciences Ovarian Cancer Treatment Of Cancer Acid Acute Myeloid Leukemia Adoptive Cell Transfer Advanced Solid Tumors
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags